Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-036024
Filing Date
2025-04-17
Accepted
2025-04-17 16:20:22
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm252403d5_defa14a.htm DEFA14A 14201
2 GRAPHIC tm252403d5_defa14aimag001.jpg GRAPHIC 8815
3 GRAPHIC tm252403d5_defa14aimag002.jpg GRAPHIC 160175
4 GRAPHIC tm252403d5_defa14aimag003.jpg GRAPHIC 181256
  Complete submission text file 0001104659-25-036024.txt   498160
Mailing Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 484-320-2930
TELA Bio, Inc. (Filer) CIK: 0001561921 (see all company filings)

EIN.: 455320061 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39130 | Film No.: 25847599
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)